IMC Chicago
HCAT icon

IMC Chicago’s Health Catalyst HCAT Stock Holding History

IMC Chicago’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8K Buy
+15,600
New +$29.3K ﹤0.01% 5635

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IMC Chicago's HCAT Position: Q1 2026 in Review

IMC Chicago opened a new position in Health Catalyst (HCAT) in Q1 2026: 18,451 shares worth $23.4K. The stake represents ﹤0.01% of the portfolio and ranks #5621 among its holdings.

130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • IMC Chicago held 18,451 shares of Health Catalyst worth $23.4K as of Q1 2026.
  • Health Catalyst was a new IMC Chicago position in Q1 2026.
  • Health Catalyst made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5621 holding.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.